Apotheek An Sofie Stragier
ActiveApotheek An Sofie Stragier has been active since 2000 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.57M and a net result of €337k. Equity remains stable across the filed fiscal years (±2.1% per year). Its solvency ranks better than 71% of 10242 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
100
/ 100
Excellent▲ +2 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+5
Solvency95▲+5
Growth78=
Stability100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €160k at 30 days acceptable
Liquidity ample (current ratio 1.86 against 1.66 in 2024), and 41.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
58.9%
Return on assets
12.7%
Age of the figures
8 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
27 d late
2024
28 d late
2023
30 d late
2022
31 d late
2021
31 d late
2020
31 d late
2019
89 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€1.57M▲ 2.6%
2024 · €1.53M
2018: €1.32M
2019: €1.50M
2020: €1.78M
2021: €1.98M
2022: €2.27M
2023: €1.67M
2024: €1.53M
2018 → 2025
Total assets
€2.66M▼ 0.5%
2024 · €2.67M
2018: €1.93M
2019: €2.12M
2020: €2.52M
2021: €2.78M
2022: €3.03M
2023: €3.34M
2024: €2.67M
2018 → 2025
Net result
€337k▲ 15.6%
2024 · €291k
2018: €273k
2019: €183k
2020: €283k
2021: €194k
2022: €292k
2023: €271k
2024: €291k
2018 → 2025
Working capital
€880k▲ 25.3%
2024 · €702k
2018: €656k
2019: €871k
2020: €1.10M
2021: €1.28M
2022: €1.34M
2023: €793k
2024: €702k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€1.98M-€2.27M▲ 14.7%€1.67M▼ 26.5%€1.53M▼ 8.4%€1.57M▲ 2.6%
Operating result€317k-€459k▲ 44.5%€413k▼ 9.9%€447k▲ 8.2%€526k▲ 17.5%
Net result€194k-€292k▲ 50.5%€271k▼ 7.2%€291k▲ 7.6%€337k▲ 15.6%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 18% above 2024 and is the highest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.66M
Fixed assets
€759k▼ 16.1%
Current assets
€1.90M▲ 7.5%
Equity and liabilities €2.66M
Equity
€1.57M▲ 2.6%
Provisions
€34k▼ 3.8%
Debt
€1.06M▼ 4.6%
The debt ratio falls from 41.5% to 39.8%: equity grows while debt is paid down.
Key figures and ratios
EBITDA
€563k▲
2024 · €485k
Cash flow
€374k▲
2024 · €329k
Solvency
58.9%▲
2024 · 57.2%
Current ratio
1.86▲
2024 · 1.66
Quick ratio
1.68▲
2024 · 1.49
Debt / equity
0.67▼
2024 · 0.73
ROE
21.5%▲
2024 · 19.1%
ROA
12.7%▲
2024 · 10.9%
Interest coverage
9.40▲
2024 · 7.73
Debt
€1.06M▼
2024 · €1.11M
Debt ≤ 1 year
€1.02M▼
2024 · €1.06M
Income taxes
€143k▲
2024 · €136k
Staff costs
€212k▲
2024 · €192k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€2.67M€2.66M▼
Fixed assets21/28€905k€759k▼
Intangible fixed assets21€37k€31k▼
Tangible fixed assets22/27€759k€728k▼
Land and buildings22€757k€728k▼
Plant, machinery and equipment23€706€380▼
Furniture and vehicles24€2k-
Financial fixed assets28€108k€0▼
Current assets29/58€1.77M€1.90M▲
Stocks and contracts in progress3€181k€190k▲
Stocks30/36€181k€190k▲
Amounts receivable within one year40/41€162k€186k▲
Trade receivables40€140k€176k▲
Other amounts receivable41€22k€10k▼
Current investments50/53€677k€447k▼
Cash at bank and in hand54/58€742k€1.07M▲
Deferred charges and accrued income490/1€5k€3k▼
Equity and liabilities
Total equity and liabilities10/49€2.67M€2.66M▼
Equity10/15€1.53M€1.57M▲
Contributions10/11€20k€20k=
Reserves13€1.51M€1.55M▲
Tax-exempt reserves132€105k€101k▼
Distributable reserves133€1.40M€1.45M▲
Profit (loss) carried forward14€2k€1k▼
Provisions and deferred taxes16€35k€34k▼
Deferred taxes168€35k€34k▼
Amounts payable17/49€1.11M€1.06M▼
Amounts payable within one year42/48€1.06M€1.02M▼
Trade debts44€45k€113k▲
Suppliers440/4€45k€113k▲
Taxes, remuneration and social security45€72k€60k▼
Taxes450/3€30k€20k▼
Remuneration and social security454/9€42k€40k▼
Other amounts payable47/48€948k€847k▼
Accrued charges and deferred income492/3€45k€39k▼
Income statement
Code20242025
Non-recurring operating income76A-€38k
Remuneration, social security and pensions62€192k€212k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€37k€37k▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€1k€44▼
Other operating charges640/8€5k€5k▼
Gross operating margin9900€683k€779k▲
Operating profit (loss)9901€447k€526k▲
Financial income75/76B€41k€13k▼
Recurring financial income75€41k€13k▼
Financial charges65/66B€63k€60k▼
Recurring financial charges65€63k€60k▼
Profit (loss) for the period before taxes9903€426k€479k▲
Transfer from deferred taxes780€1k€1k=
Income taxes67/77€136k€143k▲
Profit (loss) for the period9904€291k€337k▲
Transfer from tax-exempt reserves789€4k€4k=
Profit (loss) for the period to be appropriated9905€295k€341k▲
Appropriation of the result
Profit (loss) to be appropriated9906€299k€343k▲
Profit (loss) brought forward from the previous period14P€3k€2k▼
Transfer from equity791/2€430k€296k▼
Transfer to equity691/2€295k€341k▲
To other reserves6921€295k€341k▲
Profit to be distributed694/7€431k€297k▼
Return on contributions (dividend)694€431k€297k▼
Social balance
Average headcount (FTE)90873.13.2▲
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 27 days late
2025
31-12
Financial
Highest result since 2018net €337k ▲15.6%
Operating result €526k, net result €337k, both a record.
28-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 28 days late
2024
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 30 days late
2023
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 31 days late
2022
31-12
Financial
Equity above €2MEq €2.27M ▲14.7%
5 profitable years in a row build equity to €2.27M.
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 31 days late
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 31 days late
2020
28-10
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 89 days late
2019
31-12
Financial
Weakest financial yearnet €183k ▼32.9%
Net result drops to €183k, the lowest in the series; recovery starts the following year.
16-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 16 days late
2018
17-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 17 days late
2017
31-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brugge · 1 establishment unit since 2000
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Oostendse Steenweg 1038000 BruggeGround area
973 m²
Building footprint
333 m²
Volume, LiDAR
2,005 m³
Parcel 31808M0364/00K003, Flanders · tallest building 8.7 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
APOTHEEK AN SOFIE STRAGIER
since 20002.116.052.921
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 31808M0364/00K003 | Flanders | 973 m² | 1 · 333 m² | 8.7 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2023 · 1 entry · 1,704 EUR awarded · 1,704 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2023 | 1 | 1,704 EUR | 1,704 EUR |
Schemes
Vlaams opleidingsverlof (VOV)
Recognitions · licences · registrations
Food safety, FASFC
1 siteBrugge2.116.052.921
Legal Entity Identifier
984500X4BJ2HEF2L4B02
Similar companies · same sector, comparable size
K & K MANAGEMENT
BE 0881.071.586
Mol · Eq €1.57M
DECON
BE 0430.414.536
Maasmechelen · Eq €1.56M
APOTHEEK DUCASTEL
BE 0887.576.328
Wetteren · Eq €1.56M
APOTHEEK BENEDICTE VAN HEULE
BE 0479.422.104
Nazareth-De Pinte · Eq €1.55M
Apotheek VANAKEN - DELEU
BE 0463.364.743
Bocholt · Eq €1.55M
Of 5,209 companies in sector 47730 we hold annual accounts for 3,851. 2,616 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded07-09-2000
Fiscal year end31-12
Abbreviation NL
An Sofie Stragier
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
68201Renting and operating of own or leased residential real estate, excluding social housing
Sources
Crossroads Bank for EnterprisesNational Bank · 25 filingsAddress and cadastre registers
Data from official sources, last processed on 14-09-2026. Scores and ratios are computed by Checked and are not a credit decision.